Verve Therapeutics Inc

NASDAQ:VERV   1:58:28 PM EDT
48.33
-1.61 (-3.22%)
Earnings Announcements

Verve Therapeutics Announces Business And Program Highlights And Reports Second Quarter 2021 Financial Results

Published: 08/12/2021 10:47 GMT
Verve Therapeutics Inc (VERV) - Verve Therapeutics Announces Business and Program Highlights and Reports Second Quarter 2021 Financial Results.
Q2 Loss per Share $6.66.
Q2 Earnings per Share Estimate $-0.49 -- Refinitiv Ibes Data (analyst estimates).
Cash, Cash Equivalents and Marketable Securities Were $417.6 Million As of June 30, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.47

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.